Cargando...
TREATMENT WITH FLT3 INHIBITOR IN PATIENTS WITH FLT3-MUTATED AML IS ASSOCIATED WITH DEVELOPMENT OF SECONDARY FLT3-TKD MUTATIONS
BACKGROUND: FLT3-internal tandem duplication (ITD) mutations are found in approximately 30% of AML patients. FLT3 inhibitors have shown clinical activity in AML with FLT3-ITD but responses are usually short lived. METHODS: We reviewed 69 FLT3 mutated AML patients, treated with different FLT3 inhibit...
Gardado en:
| Main Authors: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4124083/ https://ncbi.nlm.nih.gov/pubmed/24737502 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28705 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|